Two Daiichi Sankyo drugs dealt a thumbs up and thumbs down by FDA advisory panel
May 15, 2019Research and Development, Sales and Marketing Daiichi Sankyo, FDA, pexidartinib, pharma, quizartinib
Daiichi Sankyo was left with a bittersweet taste in its mouth after it saw one of its drugs recommended for …
Pfizer & Merck’s Inlyta combo becomes first FDA-approved anti-PD-L1 therapy for kidney cancer
May 15, 2019Research and Development, Sales and Marketing FDA, Merck KGaA, Pfizer, inylta, pharma, renal cell carcinoma
The FDA has approved Bavencio (avelumab) in combination with Inlyta (axitinib) for the treatment of advanced renal cell carcinoma (RCC). …
NHS England agree to pay for Biogen’s $750,000 a year SMA treatment Spinraza
May 15, 2019Research and Development Biogen, NHS England, Spinraza, UK, pharma, sma, spinal muscular atrophy
NHS England has agreed to pay an undisclosed price for Biogen’s spinal muscle atrophy (SMA) treatment Spinraza. England’s National Health …
Gilead struck anti-competitive deals to retain dominance in HIV market, lawsuit says
May 15, 2019Research and Development AIDS, BMS, Gilead, HIV, Janssen, generic drugs
Gilead Sciences struck anti-competitive deals with Janssen and Britsol-Myers Squibb in an effort to retain dominance in the market for …
Medical Affairs 2025 – Excellence in the era of precision medicine
May 15, 2019Medical Communications, Research and Development pharma, veeva
Medical affairs is at the leading edge of a trend. As the life sciences industry shifts towards precision medicine, its …
Ex-GSK, Novartis exec named as Mundipharma’s Head of Access
May 14, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mundipharma, appointment, pharma
Mundipharma has announced that Jerome Moreau has joined the company as its new Head of Market Access. Moreau has amassed …
Prophylactic antibiotic use could halve post-birth maternal infections, study indicates
May 14, 2019Manufacturing and Production, Research and Development Antibiotics, University of Oxford, pharma
A study led by researchers at the University of Oxford has argued that the administration of preventative antibiotics to all …
FDA expands indication for Eylea to cover all stages of diabetic retinopathy
May 14, 2019Manufacturing and Production Bayer, Eylea, FDA, Regeneron, approval, pharma
The FDA has expanded the indication for Regeneron’s Eylea (aflibercept) to include all stages of diabetic retinopathy. Regeneron chief scientific …
Mental health spending varies dramatically among regions in England, analysis shows
May 14, 2019Manufacturing and Production England, NHS, UK, mental health, mind, spending
Spending on mental health varies dramatically between regions in England, according to analysis from mental health charity Mind. South Yorkshire …
MSD’s Keytruda recommended on NHS in Scotland for Stage 3 melanoma
May 14, 2019Manufacturing and Production, Sales and Marketing Cancer, MSD, Scotland, Scottish Medicines Consortium, keytruda, melanoma, pharma
MSD has revealed that Keytruda (pembrolizumab) will be made available to NHS Scotland patients after the Scottish Medicines Consortium (SMC) …
Chinese pharmaceuticals will not be subject to tariffs, US Trade Representative says
May 14, 2019Manufacturing and Production China, US, USTR, pharma, tariffs, trade
The Office of the United States Trade Representative (USTR) has said pharmaceuticals will not be subject to potential US tariffs …
The interplay between the GDPR and the EU Clinical Trials Regulation
May 13, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GDPR, clinical trial data, clinical trials, eu clinical trials regulation, pharma, trial data
Paul Kavanagh, partner at law firm Dechert, explores the relationship between GDPR and CTR, and its potential impact on the …
UK GPs are underequipped to handle growing chronic opioid use, report warns
May 13, 2019Medical Communications, Sales and Marketing NHS, UK, opioid crisis, opioids, pharma
New research from the University of East Anglia (UEA) has argued that general practitioners (GPs) in the UK are lacking …
US sees 300% increase in the number of cases of Hepatitis A
May 13, 2019Sales and Marketing CDC, hepatitis a, pharma, public health, sanitation
The number of Americans infected with Hepatitis A has increased 300% in the past three years, according to figures from …
Heart disease deaths increase for first time in 50 years
May 13, 2019Sales and Marketing BHF, UK, cardiovascular, health, heart disease, obesity
Deaths from heart disease among people under the age of 75 have increased for the first time in 50 years. …
Lilly’s Cyramza approved in US for hepatocellular carcinoma sub-population
May 13, 2019Sales and Marketing Eli Lilly, FDA, cyramza, hepatocellular carcinoma, pharma
Eli Lilly’s vascular endothelial growth factor (VEGF) receptor 2 antagonist Cyramza (ramucirumab) has received approval in the US as a …
US States allege 20 generic drugmakers fixed prices of generic drugs
May 13, 2019Sales and Marketing competition, generics, markets, price fixing, price-fixing, pricing
Forty-four US States have filed a lawsuit against 20 generic drugmakers – including Teva Pharmaceuticals – over allegations the firms …
FDA to end controversial “alternative summary reporting” of medical devices in bid to boost transparency
May 10, 2019Medical Communications, Research and Development, Sales and Marketing FDA, US, adverse events, medical devices, pharma
The FDA has revealed that it plans to terminate its “alternative summary reporting” programme which has allowed the manufacturers of …
Top Ten most popular articles on Pharmafile.com this week!
May 10, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, GSK, Innoviva, NHS, Novartis, health, migraine, pharma
This week was a particularly bad one for the NHS after it was revealed thousands of EU nurses were leaving …
Clinical trial will test long acting HIV injection
May 10, 2019Medical Communications Art, CAB, HIV, Janssen, RPV, ViiV, injectable
A long-acting, injectable HIV drug combo is to be tested in a clinical trial of 350 volunteers with HIV. The …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
